Clinical Trials Browser

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Neuroendocrine Neoplasms

Neuroblastoma, Ganglioneuroblastoma

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

Small Cell Lung Cancer Extensive Stage

Sarcoma, Ewing, Osteosarcoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Sarcoma, Ewing

Advanced NUT Carcinoma

Glioma, Central Nervous System Neoplasms

Small Cell Lung Carcinoma

Burkitt Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Leukemia, Myeloid, Acute

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Lung Neoplasms, Small Cell Lung Carcinoma

Stage I Mixed Cell Type Kidney Wilms Tumor

Lung Neoplasms

Diabetes Insipidus, Germinoma

Clinical Trials

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

MK-6070-003

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

DeLLphi-312

SEZanne

METTSEO

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

SKB500 Combinations in Patients With Small Cell Lung Cancer

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

iMATRIX GLO

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma